Compare · EOSE vs TMO
EOSE vs TMO
Side-by-side comparison of Eos Energy Enterprises Inc. (EOSE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- EOSE operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 76.8x EOSE ($2.27B).
- Over the past year, EOSE is up 60.2% and TMO is up 14.9% - EOSE leads by 45.3 points.
- EOSE has been more active in the news (19 items in the past 4 weeks vs 17 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 20 for EOSE).
- Company
- Eos Energy Enterprises Inc.
- Thermo Fisher Scientific Inc
- Price
- $6.69-5.51%
- $469.56-0.67%
- Market cap
- $2.27B
- $174.52B
- 1M return
- +4.86%
- -1.03%
- 1Y return
- +60.24%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 19
- 17
- Recent ratings
- 20
- 25
Eos Energy Enterprises Inc.
Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for utility, commercial and industrial, and renewable energy markets in the United States. The company offers stationary battery storage solutions. Its flagship product is the Eos Znyth DC battery system designed to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, New Jersey.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest EOSE
- Eos Energy Enterprises Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- Eos Energy Stockholders Approve All Proposals at 2026 Annual Meeting
- Director Nigro Joseph converted options into 3,565 shares, increasing direct ownership by 10% to 38,950 units (SEC Form 4)
- Director Walters Marian converted options into 1,782 shares, increasing direct ownership by 1% to 160,227 units (SEC Form 4)
- Director Walters Marian sold $275,400 worth of shares (30,000 units at $9.18) and exercised 30,000 shares at a strike of $1.18 (SEC Form 4)
- SEC Form 144 filed by Eos Energy Enterprises Inc.
- SEC Form SD filed by Eos Energy Enterprises Inc.
- FPUSA and Stella Energy Solutions Announce Strategic Framework Across 2+ GWh Storage Pipeline
- Director Walters Marian exercised 22,319 shares at a strike of $1.18 and sold $160,697 worth of shares (22,319 units at $7.20) (SEC Form 4)
- Needham initiated coverage on Eos Energy with a new price target
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)